I'd dig into the yeast literature a bit. They've been doing that sort of thing for awhile now. It typically involves supplementing the media with specific fatty acids and/or substrates or targeting specific enzymatic pathways involved in fatty acid metabolism via drugs or genetics.
Hi James, so is the membrane saturation that Ana refers to involve feeding cells with specific FAs and/or inhibitors, so they are incorporated de novo into the membranes?